Current Hypertension Reports 2013-02-01

Update on the angiotensin AT(2) receptor.

Claudia A McCarthy, Robert E Widdop, Kate M Denton, Emma S Jones

Index: Curr. Hypertens. Rep. 15(1) , 25-30, (2013)

Full Text: HTML

Abstract

It is quite well established that activation of the AT(2) receptor (AT(2)R) provides a counter-regulatory role to AT(1)R overactivity, particularly during pathological conditions. Indeed, a potential therapeutic role for the AT(2)R is currently being promulgated with the introduction of novel AT(2)R ligands such as compound 21 (C21). In this brief review, we will focus on recent evidence to suggest that AT(2)R exhibits promising organ protection in the context of the heart, kidney and brain, with inflammation and gender influencing outcome. However, this field is not without controversy since the 'flagship' ligand C21 has also come under scrutiny, although it is safe to say there is much evidence to support a potentially important role of AT(2)R in a number of cardiovascular diseases. This report updates recent data in this field.

Related Compounds

  • Angiotensin II R...

Related Articles:

Altered efficacy of AT1R-targeted treatment after spontaneous cancer cell-AT1R upregulation.

2011-01-01

[BMC Cancer 11 , 274, (2011)]

Angiotensin III modulates the nociceptive control mediated by the periaqueductal gray matter

2009-12-15

[Neuroscience 164(3) , 1263-73, (2009)]

Increased vascular angiotensin type 2 receptor expression and NOS-mediated mechanisms of vascular relaxation in pregnant rats.

2009-03-01

[Am. J. Physiol. Heart Circ. Physiol. 296(3) , H745-55, (2009)]

Angiotensin II type 2 receptor vasoactivity in internal mammary arteries of patients with coronary artery disease.

2007-10-01

[J. Cardiovasc. Pharmacol. 50(4) , 372-9, (2007)]

Angiotensin II AT(2) receptor decreases AT(1) receptor expression and function via nitric oxide/cGMP/Sp1 in renal proximal tubule cells from Wistar-Kyoto rats.

2012-06-01

[J. Hypertens. 30(6) , 1176-84, (2012)]

More Articles...